Food allergy and food-based therapies in neurodevelopmental disorders

Pediatric Allergy and Immunology

Volumn 25, Issue 3, 2014, Pages 218-226

  De Theije, Caroline G M ^a   Bavelaar, Bas M ^a   Lopes da Silva, Sofia ^b   Korte, Sijmen Mechiel ^a,c   Olivier, Berend ^a,c   Garssen, Johan ^a,b   Kraneveld, Aletta D ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Nutricia Nederland   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Attention deficit hyperactivity disorder; Autism spectrum disorder; Food allergy; Food based therapy; Gut brain axis; Neurodevelopment

Indexed keywords

CYTOKINE; TARGET OF RAPAMYCIN KINASE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMPLICATION; DIET THERAPY; FEMALE; FOOD ALLERGY; HUMAN; MAST CELL; MATERNAL NUTRITION; MICROFLORA; PHYSIOLOGY; PREGNANCY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CYTOKINES; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; MAST CELLS; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICROBIOTA; PREGNANCY; TOR SERINE-THREONINE KINASES;

EID: 84898829903     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12149     Document Type: Review

References (113)

1. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 2011: 12: 453-66.
2. Costa M, Brookes SJ, Hennig GW. Anatomy and physiology of the enteric nervous system. Gut 2000: 47 (Suppl. 4): iv15-9; discussion iv26.
3. Kennedy PJ, Clarke G, Quigley EM, Groeger JA, Dinan TG, Cryan JF. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev 2012: 36: 310-40.
4. Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011: 23: 187-92.
5. Pabst O, Mowat AM. Oral tolerance to food protein. Mucosal Immunol 2012: 5: 232-9.
6. Schouten B, van Esch BC, van Thuijl AO, et al. Contribution of IgE and immunoglobulin free light chain in the allergic reaction to cow's milk proteins. J Allergy Clin Immunol 2010: 125: 1308-14.
7. Costa-Pinto FA, Basso AS. Neural and behavioral correlates of food allergy. Chem Immunol Allergy 2012: 98: 222-39.
8. Addolorato G, Marsigli L, Capristo E, Caputo F, Dall'Aglio C, Baudanza P. Anxiety and depression: a common feature of health care seeking patients with irritable bowel syndrome and food allergy. Hepatogastroenterology 1998: 45: 1559-64.
9. Alpay K, Ertas M, Orhan EK, Ustay DK, Lieners C, Baykan B. Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia 2010: 30: 829-37.
10. Severance EG, Alaedini A, Yang S, et al. Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res 2012: 138: 48-53.
11. Jyonouchi H. Food allergy and autism spectrum disorders: is there a link? Curr Allergy Asthma Rep 2009: 9: 194-201.
12. Pelsser LM, Buitelaar JK, Savelkoul HF. ADHD as a (non) allergic hypersensitivity disorder: a hypothesis. Pediatr Allergy Immunol 2009: 20: 107-12.
13. Blackman JA, Gurka MJ. Developmental and behavioral comorbidities of asthma in children. J Dev Behav Pediatr 2007: 28: 92-9.
14. McQuaid EL, Kopel SJ, Nassau JH. Behavioral adjustment in children with asthma: a meta-analysis. J Dev Behav Pediatr 2001: 22: 430-9.
15. Blackman JA, Conaway MR. Changes over time in reducing developmental and behavioral comorbidities of asthma in children. J Dev Behav Pediatr 2012: 33: 24-31.
16. Chida Y, Hamer M, Steptoe A. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med 2008: 70: 102-16.
17. Meldrum SJ, D'Vaz N, Dunstan JA, et al. Allergic disease in the first year of life is associated with differences in subsequent neurodevelopment and behaviour. Early Hum Dev 2012: 88: 567-73.
18. American-Psychiatric-Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed). Washington, DC: American-Psychiatric-Association, 2000.
19. de Theije CG, Wu J, da Silva SL, et al. Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management. Eur J Pharmacol 2011: 668 (Suppl. 1): S70-80.
20. de Magistris L, Familiari V, Pascotto A, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 2010: 51: 418-24.
21. Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, Wakefield AJ. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol 2003: 23: 504-17.
22. Louis P. Does the human gut microbiota contribute to the etiology of autism spectrum disorders? Dig Dis Sci 2012: 57: 1987-9.
23. Gurney JG, McPheeters ML, Davis MM. Parental report of health conditions and health care use among children with and without autism: National Survey of Children's Health. Arch Pediatr Adolesc Med 2006: 160: 825-30.
24. Chandler S, Carcani-Rathwell I, Charman T, et al. Parent-reported gastro-intestinal symptoms in children with autism spectrum disorders. J Autism Dev Disord 2013: Advance online publication. doi: 10.1007/s10803-013-1768-0
25. Lucarelli S, Frediani T, Zingoni AM, et al. Food allergy and infantile autism. Panminerva Med 1995: 37: 137-41.
26. Jyonouchi H, Geng L, Ruby A, Reddy C, Zimmerman-Bier B. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J Pediatr 2005: 146: 605-10.
27. Afzal N, Murch S, Thirrupathy K, Berger L, Fagbemi A, Heuschkel R. Constipation with acquired megarectum in children with autism. Pediatrics 2003: 112: 939-42.
28. Barcia G, Posar A, Santucci M, Parmeggiani A. Autism and coeliac disease. J Autism Dev Disord 2008: 38: 407-8.
29. Genuis SJ, Bouchard TP. Celiac disease presenting as autism. J Child Neurol 2010: 25: 114-9.
30. Batista IC, Gandolfi L, Nobrega YK, et al. Autism spectrum disorder and celiac disease: no evidence for a link. Arq Neuropsiquiatr 2012: 70: 28-33.
31. Gupta S, Aggarwal S, Rashanravan B, Lee T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 1998: 85: 106-9.
32. Molloy CA, Morrow AL, Meinzen-Derr J, et al. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006: 172: 198-205.
33. Ashwood P, Enstrom A, Krakowiak P, et al. Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol 2008: 204: 149-53.
34. Okada K, Hashimoto K, Iwata Y, et al. Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 2007: 31: 187-90.
35. Geschwind N, Behan P. Left-handedness: association with immune disease, migraine, and developmental learning disorder. Proc Natl Acad Sci U S A 1982: 79: 5097-100.
36. Biederman J, Milberger S, Faraone SV, Lapey KA, Reed ED, Seidman LJ. No confirmation of Geschwind's hypothesis of associations between reading disability, immune disorders, and motor preference in ADHD. J Abnorm Child Psychol 1995: 23: 545-52.
37. Hammerness P, Monuteaux MC, Faraone SV, Gallo L, Murphy H, Biederman J. Reexamining the familial association between asthma and ADHD in girls. J Atten Disord 2005: 8: 136-43.
38. McGee R, Stanton WR, Sears MR. Allergic disorders and attention deficit disorder in children. J Abnorm Child Psychol 1993: 21: 79-88.
39. Gaitens T, Kaplan BJ, Freigang B. Absence of an association between IgE-mediated atopic responsiveness and ADHD symptomatology. J Child Psychol Psychiatry 1998: 39: 427-31.
40. Schmitt J, Buske-Kirschbaum A, Roessner V. Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy 2010: 65: 1506-24.
41. Suwan P, Akaramethathip D, Noipayak P. Association between allergic sensitization and attention deficit hyperactivity disorder (ADHD). Asian Pac J Allergy Immunol 2011: 29: 57-65.
42. Shyu CS, Lin HK, Lin CH, Fu LS. Prevalence of attention-deficit/hyperactivity disorder in patients with pediatric allergic disorders: a nationwide, population-based study. J Microbiol Immunol Infect 2012: 45: 237-42.
43. Tsai MC, Lin HK, Lin CH, Fu LS. Prevalence of attention deficit/hyperactivity disorder in pediatric allergic rhinitis: a nationwide population-based study. Allergy Asthma Proc 2011: 32: 41-6.
44. Tsai JD, Chang SN, Mou CH, Sung FC, Lue KH. Association between atopic diseases and attention-deficit/hyperactivity disorder in childhood: a population-based case-control study. Ann Epidemiol 2013: 23: 185-188.
45. Fasmer OB, Halmoy A, Eagan TM, Oedegaard KJ, Haavik J. Adult attention deficit hyperactivity disorder is associated with asthma. BMC Psychiatry 2011: 11: 128.
46. Ritz BW, Lord RS. Case study: the effectiveness of a dietary supplement regimen in reducing IgG-mediated food sensitivity in ADHD. Altern Ther Health Med 2005: 11: 72-5.
47. Carter CM, Urbanowicz M, Hemsley R, et al. Effects of a few food diet in attention deficit disorder. Arch Dis Child 1993: 69: 564-8.
48. Egger J, Carter CM, Graham PJ, Gumley D, Soothill JF. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet 1985: 1: 540-5.
49. Boris M, Mandel FS. Foods and additives are common causes of the attention deficit hyperactive disorder in children. Ann Allergy 1994: 72: 462-8.
50. Prescott S, Allen KJ. Food allergy: riding the second wave of the allergy epidemic. Pediatr Allergy Immunol 2011: 22: 155-60.
51. Buitelaar JK, Huizink AC, Mulder EJ, de Medina PG, Visser GH. Prenatal stress and cognitive development and temperament in infants. Neurobiol Aging 2003: 24 (Suppl. 1): S53-60; discussion S67-8.
52. Talge NM, Neal C, Glover V. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry 2007: 48: 245-61.
53. von Hertzen LC. Maternal stress and T-cell differentiation of the developing immune system: possible implications for the development of asthma and atopy. J Allergy Clin Immunol 2002: 109: 923-8.
54. Entringer S, Kumsta R, Nelson EL, Hellhammer DH, Wadhwa PD, Wust S. Influence of prenatal psychosocial stress on cytokine production in adult women. Dev Psychobiol 2008: 50: 579-87.
55. Brown AS, Patterson PH. Maternal infection and schizophrenia: implications for prevention. Schizophr Bull 2011: 37: 284-90.
56. Atladottir HO, Thorsen P, Ostergaard L, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010: 40: 1423-30.
57. Schwartzer JJ, Careaga M, Onore CE, Rushakoff JA, Berman RF, Ashwood P. Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice. Transl Psychiatry 2013: 3: e240.
58. Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med 2005: 159: 151-7.
59. Theoharides TC. Autism spectrum disorders and mastocytosis. Int J Immunopathol Pharmacol 2009: 22: 859-65.
60. Arpino C, Marzio M, D'Argenzio L, Longo B, Curatolo P. Exanthematic diseases during pregnancy and attention-deficit/hyperactivity disorder (ADHD). Eur J Paediatr Neurol 2005: 9: 363-5.
61. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007: 27: 10695-702.
62. Banks WA, Kastin AJ, Gutierrez EG. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett 1994: 179: 53-6.
63. Jarskog LF, Xiao H, Wilkie MB, Lauder JM, Gilmore JH. Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int J Dev Neurosci 1997: 15: 711-6.
64. Anderson GM, Horne WC, Chatterjee D, Cohen DJ. The hyperserotonemia of autism. Ann N Y Acad Sci 1990: 600: 331-40; discussion 341-2.
65. Kumar B, Prakash A, Sewal RK, Medhi B, Modi M. Drug therapy in autism: a present and future perspective. Pharmacol Rep 2012: 64: 1291-304.
66. Rommelse NN, Franke B, Geurts HM, Hartman CA, Buitelaar JK. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 2010: 19: 281-95.
67. Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006: 31: 2121-31.
68. Madras BK, Miller GM, Fischman AJ. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 2005: 57: 1397-409.
69. Aguilar-Valles A, Flores C, Luheshi GN. Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: relevance for schizophrenia. PLoS ONE 2010: 5: e10967.
70. Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, Feldon J, Meyer U. Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 2010: 35: 2462-78.
71. Vuillermot S, Weber L, Feldon J, Meyer U. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 2010: 30: 1270-87.
72. Aguilar-Valles A, Jung S, Poole S, Flores C, Luheshi GN. Leptin and interleukin-6 alter the function of mesolimbic dopamine neurons in a rodent model of prenatal inflammation. Psychoneuroendocrinology 2012: 37: 956-69.
73. Angelidou A, Francis K, Vasiadi M, et al. Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation 2010: 7: 48.
74. Rijnierse A, Nijkamp FP, Kraneveld AD. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol Ther 2007: 116: 207-35.
75. Hirano T, Taga T, Nakano N, et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A 1985: 82: 5490-4.
76. Lin G, Wang J, Lao X, et al. Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells. J Immunother 2012: 35: 337-43.
77. Kim MS, Kuehn HS, Metcalfe DD, Gilfillan AM. Activation and function of the mTORC1 pathway in mast cells. J Immunol 2008: 180: 4586-95.
78. Furumoto Y, Charles N, Olivera A, et al. PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability. Blood 2011: 118: 5466-75.
79. Zhou J, Blundell J, Ogawa S, et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 2009: 29: 1773-83.
80. Numis AL, Major P, Montenegro MA, Muzykewicz DA, Pulsifer MB, Thiele EA. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology 2011: 76: 981-7.
81. Muzykewicz DA, Newberry P, Danforth N, Halpern EF, Thiele EA. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav 2007: 11: 506-13.
82. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005: 57: 67-81.
83. Li X, Chauhan A, Sheikh AM, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009: 207: 111-6.
84. Diaz Heijtz R, Wang S, Anuar F, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011: 108: 3047-52.
85. Finegold SM, Molitoris D, Song Y, et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 2002: 35: S6-16.
86. Finegold SM, Dowd SE, Gontcharova V, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010: 16: 444-53.
87. Parracho HMRT, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005: 54: 987-91.
88. Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 2004: 70: 6459-65.
89. Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol 2011: 11: 22.
90. Sandler RH, Finegold SM, Bolte ER, et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000: 15: 429-35.
91. Tillisch K, Labus J, Kilpatrick L, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013: 144: 1394-401, 1401 e1-4.
92. Tazoe H, Otomo Y, Kaji I, Tanaka R, Karaki SI, Kuwahara A. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 2008: 59 (Suppl. 2): 251-62.
93. Levy SE, Hyman SL. Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing. Pediatr Ann 2003: 32: 685-91.
94. Sinha D, Efron D. Complementary and alternative medicine use in children with attention deficit hyperactivity disorder. J Paediatr Child Health 2005: 41: 23-6.
95. Whiteley P, Haracopos D, Knivsberg AM, et al. The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci 2010: 13: 87-100.
96. Pennesi CM, Klein LC. Effectiveness of the gluten-free, casein-free diet for children diagnosed with autism spectrum disorder: based on parental report. Nutr Neurosci 2012: 15: 85-91.
97. Pelsser LM, Buitelaar JK. [Favourable effect of a standard elimination diet on the behavior of young children with attention deficit hyperactivity disorder (ADHD): a pilot study]. Ned Tijdschr Geneeskd 2002: 146: 2543-7.
98. Pelsser LM, Frankena K, Toorman J, et al. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial. Lancet 2011: 377: 494-503.
99. Meguid NA, Atta HM, Gouda AS, Khalil RO. Role of polyunsaturated fatty acids in the management of Egyptian children with autism. Clin Biochem 2008: 41: 1044-8.
100. Richardson AJ. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatry 2006: 18: 155-72.
101. Murphy MG. Dietary fatty acids and membrane protein function. J Nutr Biochem 1990: 1: 68-79.
102. Calder PC. Rationale and use of n-3 fatty acids in artificial nutrition. Proceedings of the Nutrition Society 2010: 69: 565-73.
103. Engfer MB, Stahl B, Finke B, Sawatzki G, Daniel H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr 2000: 71: 1589-96.
104. Schouten B, Van Esch BC, Kormelink TG, et al. Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy. Pediatr Allergy Immunol 2011: 22: 537-42.
105. van Hoffen E, Ruiter B, Faber J, et al. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 2009: 64: 484-7.
106. Costalos C, Kapiki A, Apostolou M, Papathoma E. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev 2008: 84: 45-9.
107. Langlands SJ, Hopkins MJ, Coleman N, Cummings JH. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 2004: 53: 1610-6.
108. Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 2011: 9: 27-38.
109. Jones KL, Will MJ, Hecht PM, Parker CL, Beversdorf DQ. Maternal diet rich in omega-6 polyunsaturated fatty acids during gestation and lactation produces autistic-like sociability deficits in adult offspring. Behav Brain Res 2013: 238: 193-9.
110. Sagiv SK, Thurston SW, Bellinger DC, Amarasiriwardena C, Korrick SA. Prenatal exposure to mercury and fish consumption during pregnancy and attention-deficit/hyperactivity disorder-related behavior in children. Arch Pediatr Adolesc Med 2012: 166: 1123-31.
111. Steenweg-de Graaff J, Tiemeier H, Steegers-Theunissen RP, et al. Maternal dietary patterns during pregnancy and child internalising and externalising problems. The Generation R Study. Clin Nutr 2013: Advance online publication. doi: 10.1016/j.clnu.2013.03.002
112. Roza SJ, van Batenburg-Eddes T, Steegers EA, et al. Maternal folic acid supplement use in early pregnancy and child behavioural problems: the Generation R Study. Br J Nutr 2010: 103: 445-52.
113. Schmidt RJ, Tancredi DJ, Ozonoff S, et al. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr 2012: 96: 80-9.